Tag: #CancerPrevention
-

EARLY CANCER DIAGNOSIS IMPROVES TREATMENT OUTCOMES — FG
The Federal Government has stressed the importance of detecting cancer early, saying the stage at which the disease is diagnosed can significantly influence treatment options and the chances of a successful outcome. Dr Uchechukwu Nwokwu, National Coordinator of the National Cancer Control Plan, explained that cancer progresses through four stages, depending on how far abnormal…
-

MISINFORMATION, LATE DETECTION FUEL CANCER DEATHS IN NIGERIA – ONCOLOGIST
A Consultant Oncologist at the Federal Medical Centre, Abeokuta, Dr Lateef Salako, has identified misinformation and late detection as major factors contributing to the high mortality associated with cancer in Nigeria. Salako spoke during the 2025/2026 Recognition Day, Walimah and graduation ceremony of MIMBAR Schools in Ibadan, where he urged Nigerians to seek accurate medical…
-

EARLY CANCER DETECTION: DR. AJIBOYE URGES WOMEN TO REGULARLY SELF-EXAMINE BREASTS
Dr. Anthony Ajiboye, General Surgeon at Kwara State University Teaching Hospital, is urging women to prioritize regular self breast examinations as a simple yet crucial tool for cancer prevention. Speaking in Ilorin during the 2025 Cancer Awareness Month lecture, Dr. Ajiboye emphasized that self-exams help women spot changes in breast size, shape, skin, or lumps…
-

NTF-CCE CALLS FOR FREE HPV DNA TESTING TO FIGHT CERVICAL CANCER IN NIGERIA
The National Taskforce for Cervical Cancer Elimination (NTF-CCE) has urged the government to provide universal access to free Human Papillomavirus (HPV) DNA testing to tackle the growing cervical cancer crisis in Nigeria. Prof. Isaac Adewole, former Health Minister and NTF-CCE Chairman, spoke at the 2025 International Cancer Week in Abuja, highlighting that over 15 million…
-

CHINA LAUNCHES DOMESTIC NINE-VALENT HPV VACCINE TO EXPAND CERVICAL CANCER PROTECTION
New vaccine rollout aims to protect millions of women aged 9-45 against HPV-related cancers. China began administering its homegrown nine-valent HPV vaccine in Xiamen, targeting females aged 9 to 45 for enhanced cervical cancer prevention. Two doses are required for ages 9-17, and three for adults up to 45. Cervical cancer, linked to HPV, affects…
